Skip to main content
SpringerLink
Log in

Nonmyeloablative stem cell transplantation following a cytoreductive autograft in patients with non-Hodgkin's lymphoma who relapse after autologous transplantation

  • Correspondence
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Philip T, Guglielmi C, Hagenbeek A et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995; 333: 1540–1545.

    Article  CAS  Google Scholar 

  2. Branson K, Chopra R, Kottaridis PD et al. Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies. J Clin Oncol 2002; 20: 4022–4031.

    Article  Google Scholar 

  3. Van Besien K, Sobocinski KA, Rowlings PA et al. Allogeneic bone marrow transplantation for low-grade lymphoma. Blood 1998; 92: 1832–1836.

    CAS  Google Scholar 

  4. Robinson SP, Goldstone AH, Mackinnon S et al. Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation. Blood 2002; 100: 4310–4316.

    Article  CAS  Google Scholar 

  5. Mohty M, Fegueux N, Exbrayat C et al. Reduced intensity conditioning: enhanced graft-versus-tumor effect following dose-reduced conditioning and allogeneic transplantation for refractory lymphoid malignancies after high-dose therapy. Bone Marrow Transplant 2001; 28: 335–339.

    Article  CAS  Google Scholar 

  6. Carella AM, Cavaliere M, Lerma E et al. Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma. J Clin Oncol 2000; 18: 3918–3924.

    Article  CAS  Google Scholar 

  7. Pan D, Moskowitz CH, Zelenetz AD et al. Rituximab for aggressive non-Hodgkin's lymphomas relapsing after or refractory to autologous stem cell transplantation. Cancer J 2002; 8: 371–376.

    Article  Google Scholar 

  8. Vose JM, Bierman PJ, Anderson JR et al. Progressive disease after high-dose therapy and autologous transplantation for lymphoid malignancy: clinical course and patient follow-up. Blood 1992; 80: 2142–2148.

    CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by a grant from the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (01-PJ10-PG6-01GN16-0005).

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Chonnam National University Medical School, Gwangju, South Korea

    D-H Yang, J-J Lee, Y-K Kim, S-H Cho, I-J Chung & H-J Kim

  2. Genome Research Center for Hematopoietic Diseases, Chonnam National University HwaSun Hospital, Jeonnam, South Korea

    D-H Yang, J-J Lee, Y-K Kim, S-H Cho, I-J Chung & H-J Kim

Authors
  1. D-H Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J-J Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y-K Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S-H Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I-J Chung
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H-J Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, DH., Lee, JJ., Kim, YK. et al. Nonmyeloablative stem cell transplantation following a cytoreductive autograft in patients with non-Hodgkin's lymphoma who relapse after autologous transplantation. Bone Marrow Transplant 34, 915–916 (2004). https://doi.org/10.1038/sj.bmt.1704668

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704668

  • Springer Nature Limited

Search

Navigation